AATs	anti-angiogenic therapies
AKT	protein kinase B
BSA	bovine serum albumin
BV	bevacizumab
C-tag	cysteine-tag
DAG	diacylglicerole
DIPG	diffuse intrinsic pontine glioma
EC	ethylene dicysteine
eNOS	endothelial nitric oxide synthase
Fab	antigen-binding fragment
FAK	focal adhesion kinase
HIF-1	hypoxia inducible factor-1
hnTf	human transferrin
IL-1b	interleukin 1b
IP3	inositol triphosphate
mAb	monoclonal antibody
MBs	microbubbles
NIRF	near-infrared fluorescent
NRP	neuropilin
NSCLC	non-small cell lung cancer
N-suc-Df	N-succinyl-desferrioxamine
PIP2	phosphatidylinositol bisphosphate
PLC-γ	phospholipase C-gamma
PlGF	placental growth factor
PKC	protein kinase C
PS	polymersome
QD	quantum dot
Ram	ramucirumab
Ran	ranibizumab
RTKs	receptor tyrosine kinases
scVEGF	single-chain vascular endothelial growth factor
SFB	N-succinimidyl-4-fluorobenzoate
sVEGFR	soluble vascular endothelial growth factor receptor
TNF-α	tumour necrosis factor alpha
TPPs	tumour penetrating peptides
VEGF	vascular endothelial growth factor
VEGFR	vascular endothelial growth factor receptor
VHL	von Hippel–Lindau
VRAPs	VEGFR-associated proteins